Table 3 Effects of AEE on potential biomarkers associated with atherosclerosis in urine.
No. | RT | VIP | Formula | Metabolite | Adduction | m/z | Fold Change | Pathway | |
---|---|---|---|---|---|---|---|---|---|
HFD/Control | AEE/HFD | ||||||||
1 | 1.16 | 1.30 | C6H8O7 | Citric acid | M−H | 191.0191 | 5.23** | 0.73 | Citrate cycle |
2 | 4.23 | 1.58 | C9H17NO5 | Pantothenic acid | M−H | 218.1017 | 0.07** | 0.74 | beta-Alanine metabolism |
3 | 6.05 | 2.88 | C12H14O7 | Phenylglucuronide | M−H | 269.0654 | 4.09** | 0.93 |  |
4 | 6.29 | 2.54 | C6H6O4S | Phenol sulphate | M−H | 172.9899 | 2.54** | 0.80* |  |
5 | 6.72 | 5.00 | C9H9NO3 | Hippuric acid | M−H | 178.0494 | 0.29** | 0.93 | Phenylalanine metabolism |
6 | 7.09 | 2.68 | C8H7NO4S | Indoxyl sulfate | M−H | 212.0007 | 0.77 | 0.81 | Tryptophan metabolism |
7 | 7.64 | 2.92 | C10H11NO3 | Phenylacetylglycine | M−H | 192.0650 | 1.26** | 0.88* | Phenylalanine metabolism |
8 | 8.22 | 3.75 | C13H16O7 | p-Cresol glucuronide | M−H | 283.0811 | 1.40** | 0.88 |  |
9 | 8.68 | 1.95 | C9H10O3 | Phenyllactic acid | M−H | 165.0542 | 0.25** | 0.98 | Tropane, piperidine and pyridine alkaloid biosynthesi |
10 | 9.89 | 1.09 | C9H16O4 | Azelaic acid | M−H | 187.0960 | 0.38** | 0.61** |  |
11 | 1.70 | 1.40 | C6H6N2O | Niacinamide | M+H | 123.0555 | 0.20** | 0.57 | Nicotinate and nicotinamide metabolism |
12 | 0.88 | 1.04 | C7H19N3 | Spermidine | M+H | 146.1652 | 0.33** | 0.94 | Arginine and proline metabolism |
13 | 1.15 | 1.35 | C6H11NO2 | Pipecolic acid | M+H | 130.0863 | 0.34 | 1.67 | Lysine degradation |
14 | 1.14 | 1.08 | C8H17NO2 | DL-2-AC | M+H | 160.1331 | 0.27** | 0.96 | Â |
15 | 1.87 | 1.26 | C6H13NO2 | Leucine | M+H | 132.1018 | 0.30* | 0.71 | Valine, leucine and isoleucine degradation |
16 | 7.26 | 1.22 | C17H20N4O6 | Riboflavin | M+H | 377.1467 | 0.68** | 0.51** | Vitamin digestion and absorption |
17 | 8.74 | 1.21 | C5H9NO3S | Acetylcysteine | M+H | 164.0376 | 2.82** | 0.86 | Â |